Mark Lappe bought $849K of INBX stock

Mark Lappe, Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX), bought 10,040 shares of INBX stock worth $849K, per an SEC Form 4 filed Oct 14, 2026.

It was an open-market purchase.

The trade was reported on Oct 14, 2026.

INBX has moved -0.9% since the trade date, from $85.26 to $84.52 (Nov 6, 2026 close).